DOCSLIB.ORG

Clinical and Genomic Epidemiology of Carbapenem-Non-Susceptible Citrobacter Spp

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clinical and Genomic Epidemiology of Carbapenem-Non-Susceptible Citrobacter Spp bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.959742; this version posted February 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Clinical and genomic epidemiology of carbapenem-non-susceptible Citrobacter spp. at a 2 tertiary healthcare center over two decades 3 4 Ahmed Babiker1,2†, Daniel R. Evans1, Marissa P. Griffith1,2, Christi L. McElheny1, Mohamed 5 Hassan3, Lloyd G. Clarke1, Roberta T. Mettus1, Lee H. Harrison1,2,4, Yohei Doi1, Ryan K. Shields1, 6 Daria Van Tyne1# 7 8 1Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, 9 Pennsylvania, USA 10 2Microbial Genomic Epidemiology Laboratory, University of Pittsburgh School of Medicine, 11 Pittsburgh, Pennsylvania, USA 12 3Division of General Internal Medicine, Department of Medicine, University of Pittsburgh 13 Medical Center, Pittsburgh, Pennsylvania, USA 14 4Graduate School of Public Health, University of Pittsburgh, Pennsylvania, USA 15 16 Running Title: Genomic epidemiology of carbapenem-non-susceptible Citrobacter 17 18 † Present address: Department of Pathology and Laboratory Medicine, Emory University School 19 of Medicine, Atlanta, Georgia, USA 20 #Address correspondence to: Daria Van Tyne, [email protected] 21 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.959742; this version posted February 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 22 Abstract 23 Carbapenem-non-susceptible Citrobacter spp. (CNSC) are increasingly recognized as healthcare- 24 associated pathogens. Information regarding their clinical epidemiology, genetic diversity, and 25 mechanisms of carbapenem resistance is lacking. We examined microbiology records of adult 26 patients at the University of Pittsburgh Medical Center (UMPC) Presbyterian Hospital (PUH) from 27 2000-2018 for CNSC, as defined by ertapenem non-susceptibility. Over this timeframe, the 28 proportion of CNSC increased from 4% to 10% (P=0.03), as did carbapenem daily defined 29 doses/1000 patient days (6.52 to 34.5, R2=0.831, P<0.001), which correlated with the observed 30 increase in CNSC (lag=0 years, R2=0.660). Twenty CNSC isolates from 19 patients at PUH and 31 other UPMC hospitals were available for further analysis, including whole-genome short-read 32 sequencing and additional antimicrobial susceptibility testing. Of the 19 patients, nearly all 33 acquired CNSC in the healthcare setting and over half had polymicrobial cultures containing at 34 least one other organism. Among the 20 CNSC isolates, C. freundii was the predominant species 35 identified (60%). CNSC genomes were compared with genomes of carbapenem-susceptible 36 Citrobacter spp. from UPMC, and with other publicly available CNSC genomes. Isolates encoding 37 carbapenemases (blaKPC-2, blaKPC-3, and blaNDM-1) were also long-read sequenced, and their 38 carbapenemase-encoding plasmid sequences were compared with one another and with publicly 39 available sequences. Phylogenetic analysis of 102 UPMC Citrobacter spp. genomes showed that 40 CNSC from our setting did not cluster together. Similarly, a global phylogeny of 64 CNSC 41 genomes showed a diverse population structure. Our findings suggest that both local and global 42 CNSC populations are genetically diverse, and that CNSC harbor carbapenemase-encoding 43 plasmids found in other Enterobacterales. 44 Keywords: Carbapenem, Citrobacter, Multidrug-resistance, Carbapenemase 2 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.959742; this version posted February 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 45 Introduction 46 Carbapenem-resistant bacteria have become a major health concern worldwide (1). There are 47 limited therapeutic options for treating infections caused by these multidrug-resistant organisms, 48 resulting in greater morbidity and mortality compared to infections caused by susceptible 49 organisms (2). Furthermore, multidrug-resistant infections place an additional economic burden 50 on healthcare systems (3). In recognition of this threat, the treatment and control of carbapenem- 51 resistant organisms have been prioritized by both the Centers for Diseases Control and Prevention 52 and the World Health Organization (4, 5). 53 54 The recent increase in infections caused by carbapenem-resistant organisms in the United States 55 has been largely driven by the dissemination of plasmid-encoded carbapenemases, which are often 56 carried by members of the Enterobacterales, particularly Klebsiella pneumoniae (6, 7). However, 57 rates of other carbapenem-resistant bacterial species have also increased (8). Among them, 58 carbapenem-non-susceptible Citrobacter spp. (CNSC) have become increasingly recognized as a 59 healthcare-associated pathogen (9-13). CNSC isolates have been found to be both genotypically 60 and phenotypically diverse (14, 15), and their resistance to carbapenems is frequently caused by 61 plasmid-encoded carbapenemases, which can be readily acquired through horizontal gene transfer 62 (12, 16). 63 64 Information regarding the clinical epidemiology, genetic diversity, and mechanisms of 65 carbapenem resistance among CNSC in the United States are currently limited to a small number 66 of studies and very few isolates (9, 17-19). Here we aimed to investigate the emergence of CNSC 67 within our healthcare system using epidemiology and genomics approaches. We conducted a 3 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.959742; this version posted February 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 68 retrospective analysis of CNSC prevalence and carbapenem use over the last two decades, and 69 compared the genomes of CNSC isolates from our center with other local Citrobacter isolates, as 70 well as with CNSC genomes sampled from around the globe. We found that while the CNSC 71 sampled from our center are highly genetically diverse, their diversity is consistent with the local 72 carbapenem-susceptible Citrobacter population, as well as with CNSC sampled elsewhere. 73 74 Methods 75 Study design and isolate collection 76 This study was conducted at the University of Pittsburgh Medical Center (UPMC) Presbyterian 77 Hospital (PUH), an adult medical/surgical tertiary care hospital with 762 total beds, 150 critical 78 care unit beds, more than 32,000 yearly inpatient admissions, and over 400 solid organ transplants 79 per year. CNSC isolates were collected from both UPMC-PUH as well as other UPMC hospitals. 80 Ethics approval for this study was obtained from the Institutional Review Board of the University 81 of Pittsburgh. 82 83 To investigate CNSC epidemiology at UPMC-PUH, microbiology records of adult patients with a 84 positive clinical culture for CNSC were evaluated from January 1, 2000 to December 31, 2018. 85 Cases were excluded from re-inclusion within 90 days of any CNSC culture. Carbapenem non- 86 susceptibility was defined as non-susceptibility to any carbapenem according to the 2017 Clinical 87 Laboratory Standards Institute (CLSI) interpretative criteria (20). Antibiotic consumption was 88 measured by daily defined doses (DDDs) of any carbapenem (21). To further phenotype and 89 genotype CNSC at UPMC, 20 available CNSC isolates from 19 patients collected between 2013 90 and 2019 from were included. Isolates were considered community-associated if the organism was 4 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.21.959742; this version posted February 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 91 isolated from a specimen collected within 72 hours following hospital admission; isolates collected 92 after 72 hours were considered healthcare-associated (22). Clinical characteristics and outcomes 93 of patients with CNSC isolates that underwent further characterization were collected through 94 retrospective chart review. The primary clinical outcome was in-hospital mortality and/or transfer 95 to hospice. 96 97 CNSC isolate characterization 98 Initial species assignment was performed using standard clinical microbiology laboratory 99 methods, and was confirmed or modified after whole-genome sequencing. Carbapenem non- 100 susceptibility was initially determined by standard clinical microbiology laboratory methods, and 101 was confirmed by the Kirby-Bauer disk diffusion method as per the 2017 Clinical Laboratory 102 Standards Institute (CLSI) interpretative criteria (20). Susceptibility to additional agents was 103 determined by the broth microdilution method (20). Presence of carbapenemase enzyme activity 104 was assessed by modified carbapenem inactivation (mCIM) test (23). 105 106 Genome sequencing and analysis 107 Genomic DNA was extracted from pure overnight cultures of single bacterial colonies using a 108 Qiagen DNeasy Blood & Tissue Kit according to the manufacturer’s instructions (Qiagen, 109 Germantown, MD). Library construction and sequencing were conducted using the Illumina 110 Nextera NGS Library Prep Kit or the Illumina Nextera XT DNA Library Prep Kit (Illumina,
Load more

Recommended publications
  • Determination of the Effects That a Previously Uncharacterized Secreted Product from Klebsiella Pneumoniae Has on Citrobacter Fr
    East Tennessee State University Digital Commons @ East Tennessee State University Undergraduate Honors Theses Student Works 5-2017 Determination of the effects that a previously uncharacterized secreted product from Klebsiella pneumoniae has on Citrobacter freundii and Enterobacter cloacae biofilms Cody M. Hastings Follow this and additional works at: https://dc.etsu.edu/honors Part of the Bacteria Commons, Bacteriology Commons, Biological Phenomena, Cell Phenomena, and Immunity Commons, Cell and Developmental Biology Commons, Medical Cell Biology Commons, Medical Microbiology Commons, Microbial Physiology Commons, and the Pathogenic Microbiology Commons Recommended Citation Hastings, Cody M., "Determination of the effects that a previously uncharacterized secreted product from Klebsiella pneumoniae has on Citrobacter freundii and Enterobacter cloacae biofilms" (2017). Undergraduate Honors Theses. Paper 419. https://dc.etsu.edu/ honors/419 This Honors Thesis - Withheld is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State University. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of Digital Commons @ East Tennessee State University. For more information, please contact [email protected]. Determination of the effects that a previously uncharacterized secreted product from Klebsiella pneumoniae has on Citrobacter freundii and Enterobacter cloacae biofilms By Cody Hastings An Undergraduate Thesis Submitted in Partial Fulfillment of the Requirements
    [Show full text]
  • Bacterial Dissimilation of Citric Acid Carl Robert Brewer Iowa State College
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1939 Bacterial dissimilation of citric acid Carl Robert Brewer Iowa State College Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Microbiology Commons Recommended Citation Brewer, Carl Robert, "Bacterial dissimilation of citric acid " (1939). Retrospective Theses and Dissertations. 13227. https://lib.dr.iastate.edu/rtd/13227 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Brol<en or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps.
    [Show full text]
  • Upper and Lower Case Letters to Be Used
    Isolation, characterization and genome sequencing of a soil-borne Citrobacter freundii strain capable of detoxifying trichothecene mycotoxins by Rafiqul Islam A Thesis Presented to The University of Guelph In Partial Fulfilment of Requirements for the Degree of Doctor of Philosophy in Plant Agriculture Guelph, Ontario, Canada © Rafiqul Islam, April, 2012 ABSTRACT ISOLATION, CHARACTERIZATION AND GENOME SEQUENCING OF A SOIL- BORNE CITROBACTER FREUNDII STRAIN CAPABLE OF DETOXIFIYING TRICHOTHECENE MYCOTOXINS Rafiqul Islam Advisors: University of Guelph, 2012 Dr. K. Peter Pauls Dr. Ting Zhou Cereals are frequently contaminated with tricthothecene mycotoxins, like deoxynivalenol (DON, vomitoxin), which are toxic to humans, animals and plants. The goals of the research were to discover and characterize microbes capable of detoxifying DON under aerobic conditions and moderate temperatures. To identify microbes capable of detoxifying DON, five soil samples collected from Southern Ontario crop fields were tested for the ability to convert DON to a de-epoxidized derivative. One soil sample showed DON de-epoxidation activity under aerobic conditions at 22-24°C. To isolate the microbes responsible for DON detoxification (de-epoxidation) activity, the mixed culture was grown with antibiotics at 50ºC for 1.5 h and high concentrations of DON. The treatments resulted in the isolation of a pure DON de-epoxidating bacterial strain, ADS47, and phenotypic and molecular analyses identified the bacterium as Citrobacter freundii. The bacterium was also able to de-epoxidize and/or de-acetylate 10 other food-contaminating trichothecene mycotoxins. A fosmid genomic DNA library of strain ADS47 was prepared in E. coli and screened for DON detoxification activity. However, no library clone was found with DON detoxification activity.
    [Show full text]
  • 1471-2180-13-114.Pdf (2.637Mb)
    Baseline survey of the anatomical microbial ecology of an important food plant: Solanum lycopersicum (tomato) Ottesen et al. Ottesen et al. BMC Microbiology 2013, 13:114 http://www.biomedcentral.com/1471-2180/13/114 Ottesen et al. BMC Microbiology 2013, 13:114 http://www.biomedcentral.com/1471-2180/13/114 RESEARCH ARTICLE Open Access Baseline survey of the anatomical microbial ecology of an important food plant: Solanum lycopersicum (tomato) Andrea R Ottesen1*, Antonio González Peña3, James R White2, James B Pettengill1, Cong Li1, Sarah Allard1, Steven Rideout4, Marc Allard1, Thomas Hill1, Peter Evans1, Errol Strain1, Steven Musser1, Rob Knight3 and Eric Brown1 Abstract Background: Research to understand and control microbiological risks associated with the consumption of fresh fruits and vegetables has examined many environments in the farm to fork continuum. An important data gap however, that remains poorly studied is the baseline description of microflora that may be associated with plant anatomy either endemically or in response to environmental pressures. Specific anatomical niches of plants may contribute to persistence of human pathogens in agricultural environments in ways we have yet to describe. Tomatoes have been implicated in outbreaks of Salmonella at least 17 times during the years spanning 1990 to 2010. Our research seeks to provide a baseline description of the tomato microbiome and possibly identify whether or not there is something distinctive about tomatoes or their growing ecology that contributes to persistence of Salmonella in this important food crop. Results: DNA was recovered from washes of epiphytic surfaces of tomato anatomical organs; leaves, stems, roots, flowers and fruits of Solanum lycopersicum (BHN602), grown at a site in close proximity to commercial farms previously implicated in tomato-Salmonella outbreaks.
    [Show full text]
  • Ohio Department of Health, Bureau of Infectious Diseases Disease Name Class A, Requires Immediate Phone Call to Local Health
    Ohio Department of Health, Bureau of Infectious Diseases Reporting specifics for select diseases reportable by ELR Class A, requires immediate phone Susceptibilities specimen type Reportable test name (can change if Disease Name other specifics+ call to local health required* specifics~ state/federal case definition or department reporting requirements change) Culture independent diagnostic tests' (CIDT), like BioFire panel or BD MAX, E. histolytica Stain specimen = stool, bile results should be sent as E. histolytica DNA fluid, duodenal fluid, 260373001^DETECTED^SCT with E. histolytica Antigen Amebiasis (Entamoeba histolytica) No No tissue large intestine, disease/organism-specific DNA LOINC E. histolytica Antibody tissue small intestine codes OR a generic CIDT-LOINC code E. histolytica IgM with organism-specific DNA SNOMED E. histolytica IgG codes E. histolytica Total Antibody Ova and Parasite Anthrax Antibody Anthrax Antigen Anthrax EITB Acute Anthrax EITB Convalescent Anthrax Yes No Culture ELISA PCR Stain/microscopy Stain/spore ID Eastern Equine Encephalitis virus Antibody Eastern Equine Encephalitis virus IgG Antibody Eastern Equine Encephalitis virus IgM Arboviral neuroinvasive and non- Eastern Equine Encephalitis virus RNA neuroinvasive disease: Eastern equine California serogroup virus Antibody encephalitis virus disease; LaCrosse Equivocal results are accepted for all California serogroup virus IgG Antibody virus disease (other California arborviral diseases; California serogroup virus IgM Antibody specimen = blood, serum, serogroup
    [Show full text]
  • Use of the Diagnostic Bacteriology Laboratory: a Practical Review for the Clinician
    148 Postgrad Med J 2001;77:148–156 REVIEWS Postgrad Med J: first published as 10.1136/pmj.77.905.148 on 1 March 2001. Downloaded from Use of the diagnostic bacteriology laboratory: a practical review for the clinician W J Steinbach, A K Shetty Lucile Salter Packard Children’s Hospital at EVective utilisation and understanding of the Stanford, Stanford Box 1: Gram stain technique University School of clinical bacteriology laboratory can greatly aid Medicine, 725 Welch in the diagnosis of infectious diseases. Al- (1) Air dry specimen and fix with Road, Palo Alto, though described more than a century ago, the methanol or heat. California, USA 94304, Gram stain remains the most frequently used (2) Add crystal violet stain. USA rapid diagnostic test, and in conjunction with W J Steinbach various biochemical tests is the cornerstone of (3) Rinse with water to wash unbound A K Shetty the clinical laboratory. First described by Dan- dye, add mordant (for example, iodine: 12 potassium iodide). Correspondence to: ish pathologist Christian Gram in 1884 and Dr Steinbach later slightly modified, the Gram stain easily (4) After waiting 30–60 seconds, rinse with [email protected] divides bacteria into two groups, Gram positive water. Submitted 27 March 2000 and Gram negative, on the basis of their cell (5) Add decolorising solvent (ethanol or Accepted 5 June 2000 wall and cell membrane permeability to acetone) to remove unbound dye. Growth on artificial medium Obligate intracellular (6) Counterstain with safranin. Chlamydia Legionella Gram positive bacteria stain blue Coxiella Ehrlichia Rickettsia (retained crystal violet).
    [Show full text]
  • Citrobacter Koseri, Levinea Malonatica
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Jan. 1990, p. 107-108 Vol. 40, No. 1 0020-7713/90/010107-02$02.oo/o Copyright 0 1990, International Union of Microbiological Societies Correct Names of the Species Citrobacter koseri, Levinea malonatica , and Citrobacter diversus Request for an Opinion WILHELM FREDERIKSEN Department of Diagnostic Bacteriology and Antibiotics, Statens Seruminstitut, DK-2300 Copenhagen S,Denmark The single species carrying the three names Citrobacter koseri, Levinea malonatica, and Citrobacter diversus differs by at least eight characteristics from Citrobacter diversum as described by Werkman and Gillen in 1932. It is obviously not the same organism. Accordingly, the species should not carry the name proposed by Werkman and Gillen. I request that the name Citrobacter diversus be placed on the list of nomina rejicienda. Citrobacter koseri is the correct name. Levinea koseri is a correct combination when the genus Levinea is accepted. The epithet maZoonatica is a later synonym of the epithet koseri. In 1932 Werkman and Gillen (7) proposed a new genus, taxon C. diversum described by Werkman and Gillen in the Citrobacter, containing seven species. The description of following characteristics: motility, production of H,S, and Citrobacter diversum (sic) of Werkman and Gillen was based production of acid from inositol and raffinose. To this can be on two strains. These strains have not been kept available in added production of acid from glycogen, melizitose, starch, collections, and the name C. diversum did not come into and galactose, as Table 1 shows. general use. Ewing and Davis obviously accepted four deviations to In 1970 Frederiksen (4) described a new species which he lead to the statement about reactions “similar to those named Citrobacter koseri.
    [Show full text]
  • Biomedical Applications of Bacteria-Derived Polymers
    polymers Review Biomedical Applications of Bacteria-Derived Polymers Jonathan David Hinchliffe, Alakananda Parassini Madappura, Syed Mohammad Daniel Syed Mohamed and Ipsita Roy * Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield S1 3JD, UK; jhinchliffe3@sheffield.ac.uk (J.D.H.); [email protected] (A.P.M.); smdsyedmohamed1@sheffield.ac.uk (S.M.D.S.M.) * Correspondence: I.Roy@sheffield.ac.uk; Tel.: +44-11-4222-5962 Abstract: Plastics have found widespread use in the fields of cosmetic, engineering, and medical sciences due to their wide-ranging mechanical and physical properties, as well as suitability in biomedical applications. However, in the light of the environmental cost of further upscaling current methods of synthesizing many plastics, work has recently focused on the manufacture of these polymers using biological methods (often bacterial fermentation), which brings with them the advantages of both low temperature synthesis and a reduced reliance on potentially toxic and non-eco-friendly compounds. This can be seen as a boon in the biomaterials industry, where there is a need for highly bespoke, biocompatible, processable polymers with unique biological properties, for the regeneration and replacement of a large number of tissue types, following disease. However, barriers still remain to the mass-production of some of these polymers, necessitating new research. This review attempts a critical analysis of the contemporary literature concerning the use of a number of bacteria-derived polymers in the context of biomedical applications, including the biosynthetic Citation: Hinchliffe, J.D.; Parassini pathways and organisms involved, as well as the challenges surrounding their mass production.
    [Show full text]
  • Microbiologically Contaminated and Over-Preserved Cosmetic Products According Rapex 2008–2014
    cosmetics Article Microbiologically Contaminated and Over-Preserved Cosmetic Products According Rapex 2008–2014 Edlira Neza * and Marisanna Centini Department of Biotechnologies, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, Siena 53100, Italy; [email protected] * Correspondence: [email protected]; Tel.: +355-685-038-408 Academic Editors: Lidia Sautebin and Immacolata Caputo Received: 25 December 2015; Accepted: 25 January 2016; Published: 30 January 2016 Abstract: We investigated the Rapid Alert System (RAPEX) database from January 2008 until week 26 of 2014 to give information to consumers about microbiologically contaminated cosmetics and over-preserved cosmetic products. Chemical risk was the leading cause of the recalls (87.47%). Sixty-two cosmetic products (11.76%) were recalled because they were contaminated with pathogenic or potentially pathogenic microorganisms. Pseudomonas aeruginosa was the most frequently found microorganism. Other microorganisms found were: Mesophilic aerobic microorganisms, Staphylococcus aureus, Candida albicans, Enterococcus spp., Enterobacter cloacae, Enterococcus faecium, Enterobacter gergoviae, Rhizobium radiobacter, Burkholderia cepacia, Serratia marcescens, Achromabacter xylosoxidans, Klebsiella oxytoca, Bacillus firmus, Pantoea agglomerans, Pseudomonas putida, Klebsiella pneumoniae and Citrobacter freundii. Nine cosmetic products were recalled because they contained methylisothiazolinone (0.025%–0.36%), benzalkonium chloride (1%), triclosan (0.4%) in concentrations higher than the limits allowed by European Regulation 1223/2009. Fifteen products were recalled for the presence of methyldibromo glutaronitrile, a preservative banned for use in cosmetics. Thirty-two hair treatment products were recalled because they contained high concentrations of formaldehyde (0.3%–25%). Keywords: microbiologically contaminated; over-preserved cosmetics; formaldehyde; RAPEX 1. Introduction The European Commission (EC) has an early warning system for safety management called the Rapid Alert System (RAPEX).
    [Show full text]
  • From Genotype to Phenotype: Inferring Relationships Between Microbial Traits and Genomic Components
    From genotype to phenotype: inferring relationships between microbial traits and genomic components Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakult¨at der Heinrich-Heine-Universit¨atD¨usseldorf vorgelegt von Aaron Weimann aus Oberhausen D¨usseldorf,29.08.16 aus dem Institut f¨urInformatik der Heinrich-Heine-Universit¨atD¨usseldorf Gedruckt mit der Genehmigung der Mathemathisch-Naturwissenschaftlichen Fakult¨atder Heinrich-Heine-Universit¨atD¨usseldorf Referent: Prof. Dr. Alice C. McHardy Koreferent: Prof. Dr. Martin J. Lercher Tag der m¨undlichen Pr¨ufung: 24.02.17 Selbststandigkeitserkl¨ arung¨ Hiermit erkl¨areich, dass ich die vorliegende Dissertation eigenst¨andigund ohne fremde Hilfe angefertig habe. Arbeiten Dritter wurden entsprechend zitiert. Diese Dissertation wurde bisher in dieser oder ¨ahnlicher Form noch bei keiner anderen Institution eingereicht. Ich habe bisher keine erfolglosen Promotionsversuche un- ternommen. D¨usseldorf,den . ... ... ... (Aaron Weimann) Statement of authorship I hereby certify that this dissertation is the result of my own work. No other person's work has been used without due acknowledgement. This dissertation has not been submitted in the same or similar form to other institutions. I have not previously failed a doctoral examination procedure. Summary Bacteria live in almost any imaginable environment, from the most extreme envi- ronments (e.g. in hydrothermal vents) to the bovine and human gastrointestinal tract. By adapting to such diverse environments, they have developed a large arsenal of enzymes involved in a wide variety of biochemical reactions. While some such enzymes support our digestion or can be used for the optimization of biotechnological processes, others may be harmful { e.g. mediating the roles of bacteria in human diseases.
    [Show full text]
  • Carbapenem-Resistant Enterobacteriaceae a Microbiological Overview of (CRE) Carbapenem-Resistant Enterobacteriaceae
    PREVENTION IN ACTION MY bugaboo Carbapenem-resistant Enterobacteriaceae A microbiological overview of (CRE) carbapenem-resistant Enterobacteriaceae. by Irena KennelEy, PhD, aPRN-BC, CIC This agar culture plate grew colonies of Enterobacter cloacae that were both characteristically rough and smooth in appearance. PHOTO COURTESY of CDC. GREETINGS, FELLOW INFECTION PREVENTIONISTS! THE SCIENCE OF infectious diseases involves hundreds of bac- (the “bug parade”). Too much information makes it difficult to teria, viruses, fungi, and protozoa. The amount of information tease out what is important and directly applicable to practice. available about microbial organisms poses a special problem This quarter’s My Bugaboo column will feature details on the CRE to infection preventionists. Obviously, the impact of microbial family of bacteria. The intention is to convey succinct information disease cannot be overstated. Traditionally the teaching of to busy infection preventionists for common etiologic agents of microbiology has been based mostly on memorization of facts healthcare-associated infections. 30 | SUMMER 2013 | Prevention MULTIDRUG-resistant GRAM-NEGative ROD ALert: After initial outbreaks in the northeastern U.S., CRE bacteria have THE CDC SAYS WE MUST ACT NOW! emerged in multiple species of Gram-negative rods worldwide. They Carbapenem-resistant Enterobacteriaceae (CRE) infections come have created significant clinical challenges for clinicians because they from bacteria normally found in a healthy person’s digestive tract. are not consistently identified by routine screening methods and are CRE bacteria have been associated with the use of medical devices highly drug-resistant, resulting in delays in effective treatment and a such as: intravenous catheters, ventilators, urinary catheters, and high rate of clinical failures.
    [Show full text]
  • International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/Ijsem.0.001485
    International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/ijsem.0.001485 Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Mobolaji Adeolu,† Seema Alnajar,† Sohail Naushad and Radhey S. Gupta Correspondence Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Radhey S. Gupta L8N 3Z5, Canada [email protected] Understanding of the phylogeny and interrelationships of the genera within the order ‘Enterobacteriales’ has proven difficult using the 16S rRNA gene and other single-gene or limited multi-gene approaches. In this work, we have completed comprehensive comparative genomic analyses of the members of the order ‘Enterobacteriales’ which includes phylogenetic reconstructions based on 1548 core proteins, 53 ribosomal proteins and four multilocus sequence analysis proteins, as well as examining the overall genome similarity amongst the members of this order. The results of these analyses all support the existence of seven distinct monophyletic groups of genera within the order ‘Enterobacteriales’. In parallel, our analyses of protein sequences from the ‘Enterobacteriales’ genomes have identified numerous molecular characteristics in the forms of conserved signature insertions/deletions, which are specifically shared by the members of the identified clades and independently support their monophyly and distinctness. Many of these groupings, either in part or in whole, have been recognized in previous evolutionary studies, but have not been consistently resolved as monophyletic entities in 16S rRNA gene trees. The work presented here represents the first comprehensive, genome- scale taxonomic analysis of the entirety of the order ‘Enterobacteriales’.
    [Show full text]